Search

Displaying results 6211 - 6220 of 10000 in total
  1. Pathway

    Cardiolipin Biosynthesis CL(10:0/20:0/20:0/22:0)

    smpdb.ca/view/SMP0178971
    Metabolic

    Cardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  2. Pathway

    Cardiolipin Biosynthesis CL(10:0/20:0/20:0/23:0)

    smpdb.ca/view/SMP0178972
    Metabolic

    Cardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  3. Pathway

    Cardiolipin Biosynthesis CL(10:0/20:0/20:0/25:0)

    smpdb.ca/view/SMP0178974
    Metabolic

    Cardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  4. Drug

    Honey

    go.drugbank.com/drugs/DB14242
    ApprovedInvestigational

    It is not an approved drug.

    Mixtures: Gongjinhyang Mi Luxury BaseSynonyms: Feng Mi
  5. Drug

    Morus alba pollen

    go.drugbank.com/drugs/DB10480
    Approved

    Morus alba pollen is the pollen of the Morus alba plant. Morus alba pollen is mainly used in allergenic testing.

    Mixtures: Western 10 Tree Pollen Mix, Western 10 Tree Pollen Mix
  6. Drug

    Teprasiran

    go.drugbank.com/drugs/DB15064
    Investigational

    Teprasiran is under investigation in clinical trial NCT03510897 (QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery).

  7. Drug

    Rubidium Rb-82

    go.drugbank.com/drugs/DB09479
    ApprovedInvestigational

    It is indicated for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected

  8. Drug

    Equine Botulinum Neurotoxin G Immune FAB2

    go.drugbank.com/drugs/DB13899
    Approved

    It is intravenously administered for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes G in adults and pediatric patients. … Equine Botulinum Neurotoxin G Immune FAB2 is composed of a mixture of immune globulin fragments purified from plasma of horses that were previously immunized with botulinum toxin serotype G.

    Synonyms: Botulinum Neurotoxin G immune FAB2 (equine), BOTULINUM NEUROTOXIN G IMMUNE FAB2, EQUINE
  9. Drug

    Equine Botulinum Neurotoxin D Immune FAB2

    go.drugbank.com/drugs/DB13902
    Approved

    It is intravenously administered for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes D in adults and pediatric patients.

  10. Drug

    beta-Escin

    go.drugbank.com/drugs/DB15774
    Investigational

    Mixtures: PREPA-S SPREY, 100 ML, PREPAGEL %1+%5 JEL, 40 G